Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 23, 2021 at 04:28 am EDT
Share
Jiangsu Apon Medical Technology Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 102.316 million compared to CNY 37.146 million a year ago. Operating income was CNY 22.228 million compared to CNY 6.343 million a year ago. Net income was CNY 19.258 million compared to CNY 8.872 million a year ago. Basic earnings per share from continuing operations was CNY 0.1833 compared to CNY 0.0845 a year ago.
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.
JIANGSU APON MEDICAL TECHNOLOGY CO., LTD. 
